The effect of ω-fatty acids on mrna expression level of PPARγ in patients with gastric adenocarcinoma

Background: The antineoplastic role of peroxisome proliferator-activated receptor gamma (PPARγ) ligandshas previously been demonstrated in several gastric cancer cell lines. Activation of PPARγ by polyunsaturated fatty acids (PUFAs) inhibits growth and proliferationof tumor cells. In this double-bli...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2016
Автори: Hosseinzadeh, A., Somi, M.-H., Dolatkhah, H., Esfahani, A., Kafil, H.S., Ardebili, S.M.M.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2016
Назва видання:Experimental Oncology
Теми:
Онлайн доступ:http://dspace.nbuv.gov.ua/handle/123456789/137807
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:The effect of ω-fatty acids on mrna expression level of PPARγ in patients with gastric adenocarcinoma / A. Hosseinzadeh, M.-H. Somi, H. Dolatkhah, A. Esfahani, H.S. Kafil, S.M.M. Ardebili // Experimental Oncology. — 2016 — Т. 38, № 3. — С. 191–194. — Бібліогр.: 28 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id irk-123456789-137807
record_format dspace
spelling irk-123456789-1378072018-06-22T15:22:01Z The effect of ω-fatty acids on mrna expression level of PPARγ in patients with gastric adenocarcinoma Hosseinzadeh, A. Somi, M.-H. Dolatkhah, H. Esfahani, A. Kafil, H.S. Ardebili, S.M.M. Original contributions Background: The antineoplastic role of peroxisome proliferator-activated receptor gamma (PPARγ) ligandshas previously been demonstrated in several gastric cancer cell lines. Activation of PPARγ by polyunsaturated fatty acids (PUFAs) inhibits growth and proliferationof tumor cells. In this double-blind clinical study, we evaluate the effect of PUFAs on PPARγ mRNA expression in patients with gastric adenocarcinoma. Materials and Methods: A total of 34 chemotherapy-naive patients diagnosed with gastric adenocarcinoma were enrolled in the present study. According to treatment strategies, all subjects were divided into two groups, the first group (17 individuals) received cisplatin without supplements and the second group (17 individuals) received cisplatin plus orally administered PUFAs supplements for 3 weeks. The gastric biopsy samples were obtained from all participants before and after treatment, and PPARγ mRNA expression levels were evaluated by quantitative real-time polymerase chain reaction using validated reference genes. Results: Our findings revealed that PPARγ mRNA expression is significantly upregulated in group II afterreceiving cisplatin plus orally administered PUFAs supplements for three weeks (p < 0.0001), whereas PPARγ mRNA expression did not show significant alteration in group I after receiving cisplatin alone. Conclusion: The results of the study evidence that PPARγ may act as a potential target for the therapy of human gastric adenocarcinoma. 2016 Article The effect of ω-fatty acids on mrna expression level of PPARγ in patients with gastric adenocarcinoma / A. Hosseinzadeh, M.-H. Somi, H. Dolatkhah, A. Esfahani, H.S. Kafil, S.M.M. Ardebili // Experimental Oncology. — 2016 — Т. 38, № 3. — С. 191–194. — Бібліогр.: 28 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/137807 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
language English
topic Original contributions
Original contributions
spellingShingle Original contributions
Original contributions
Hosseinzadeh, A.
Somi, M.-H.
Dolatkhah, H.
Esfahani, A.
Kafil, H.S.
Ardebili, S.M.M.
The effect of ω-fatty acids on mrna expression level of PPARγ in patients with gastric adenocarcinoma
Experimental Oncology
description Background: The antineoplastic role of peroxisome proliferator-activated receptor gamma (PPARγ) ligandshas previously been demonstrated in several gastric cancer cell lines. Activation of PPARγ by polyunsaturated fatty acids (PUFAs) inhibits growth and proliferationof tumor cells. In this double-blind clinical study, we evaluate the effect of PUFAs on PPARγ mRNA expression in patients with gastric adenocarcinoma. Materials and Methods: A total of 34 chemotherapy-naive patients diagnosed with gastric adenocarcinoma were enrolled in the present study. According to treatment strategies, all subjects were divided into two groups, the first group (17 individuals) received cisplatin without supplements and the second group (17 individuals) received cisplatin plus orally administered PUFAs supplements for 3 weeks. The gastric biopsy samples were obtained from all participants before and after treatment, and PPARγ mRNA expression levels were evaluated by quantitative real-time polymerase chain reaction using validated reference genes. Results: Our findings revealed that PPARγ mRNA expression is significantly upregulated in group II afterreceiving cisplatin plus orally administered PUFAs supplements for three weeks (p < 0.0001), whereas PPARγ mRNA expression did not show significant alteration in group I after receiving cisplatin alone. Conclusion: The results of the study evidence that PPARγ may act as a potential target for the therapy of human gastric adenocarcinoma.
format Article
author Hosseinzadeh, A.
Somi, M.-H.
Dolatkhah, H.
Esfahani, A.
Kafil, H.S.
Ardebili, S.M.M.
author_facet Hosseinzadeh, A.
Somi, M.-H.
Dolatkhah, H.
Esfahani, A.
Kafil, H.S.
Ardebili, S.M.M.
author_sort Hosseinzadeh, A.
title The effect of ω-fatty acids on mrna expression level of PPARγ in patients with gastric adenocarcinoma
title_short The effect of ω-fatty acids on mrna expression level of PPARγ in patients with gastric adenocarcinoma
title_full The effect of ω-fatty acids on mrna expression level of PPARγ in patients with gastric adenocarcinoma
title_fullStr The effect of ω-fatty acids on mrna expression level of PPARγ in patients with gastric adenocarcinoma
title_full_unstemmed The effect of ω-fatty acids on mrna expression level of PPARγ in patients with gastric adenocarcinoma
title_sort effect of ω-fatty acids on mrna expression level of pparγ in patients with gastric adenocarcinoma
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
publishDate 2016
topic_facet Original contributions
url http://dspace.nbuv.gov.ua/handle/123456789/137807
citation_txt The effect of ω-fatty acids on mrna expression level of PPARγ in patients with gastric adenocarcinoma / A. Hosseinzadeh, M.-H. Somi, H. Dolatkhah, A. Esfahani, H.S. Kafil, S.M.M. Ardebili // Experimental Oncology. — 2016 — Т. 38, № 3. — С. 191–194. — Бібліогр.: 28 назв. — англ.
series Experimental Oncology
work_keys_str_mv AT hosseinzadeha theeffectofōfattyacidsonmrnaexpressionlevelofpparginpatientswithgastricadenocarcinoma
AT somimh theeffectofōfattyacidsonmrnaexpressionlevelofpparginpatientswithgastricadenocarcinoma
AT dolatkhahh theeffectofōfattyacidsonmrnaexpressionlevelofpparginpatientswithgastricadenocarcinoma
AT esfahania theeffectofōfattyacidsonmrnaexpressionlevelofpparginpatientswithgastricadenocarcinoma
AT kafilhs theeffectofōfattyacidsonmrnaexpressionlevelofpparginpatientswithgastricadenocarcinoma
AT ardebilismm theeffectofōfattyacidsonmrnaexpressionlevelofpparginpatientswithgastricadenocarcinoma
AT hosseinzadeha effectofōfattyacidsonmrnaexpressionlevelofpparginpatientswithgastricadenocarcinoma
AT somimh effectofōfattyacidsonmrnaexpressionlevelofpparginpatientswithgastricadenocarcinoma
AT dolatkhahh effectofōfattyacidsonmrnaexpressionlevelofpparginpatientswithgastricadenocarcinoma
AT esfahania effectofōfattyacidsonmrnaexpressionlevelofpparginpatientswithgastricadenocarcinoma
AT kafilhs effectofōfattyacidsonmrnaexpressionlevelofpparginpatientswithgastricadenocarcinoma
AT ardebilismm effectofōfattyacidsonmrnaexpressionlevelofpparginpatientswithgastricadenocarcinoma
first_indexed 2023-10-18T21:14:50Z
last_indexed 2023-10-18T21:14:50Z
_version_ 1796152315076411392